Sign in
CompletedPhase 1

A study to examine the effects of oral NTX-1955 on the brain in healthy adults.

Key facts

Who runs it
Newleos Therapeutics Inc.
Where
Netherlands1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 1
People taking part
18 people enrolled
Started
24 Jun 2025
Ended
22 Dec 2025
Type of study
Interventional
Record updated
16 September 2025

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Can take part

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
16 September 2025